Search results
Biopharmaceuticals executive · Experienced in the creation and growth of startups to Public life science companies. Therapeutic areas of interest are oncology, genetic medicines and transgenic ...
- 500+
- New Adventure
- University of Illinois at Medical Center
Dr. Ramesh Kumar, Ph.D., is a biotechnology executive with over three decades of management experience in private and public companies. He co-founded Onconova Therapeutics, Inc. in 1998 and transitioned to an Advisory role in early 2019.
Dr. Ramesh Kumar, Ph.D., is a biotechnology executive with over three decades of management experience in private and public companies. He co-founded Onconova Therapeutics, Inc. in 1998 and transitioned to an Advisory role in early 2019.
Ramesh Kumar, Ph.D. President and Chief Executive Officer Onconova Therapeutics, Inc. 375 Pheasant Run Newtown, PA 18940 Re: Onconova Therapeutics, Inc. Registration Statement on Form S-1 Filed December 29, 2017 File No. 333-222374 Dear Dr. Kumar:
Small Molecule Cancer Drugs, Nasdaq: ONTX, Dr. Ramesh Kumar, PhD, With their drug Rigosertib now in Phase III Trials for the Bone Marrow Disorder Myelodysplastic Syndrome used in over 500 Patients, Onconova Therapeutics brings hope to many Elderly Suffering from this Devastating Disease, CEO Interviews 2017, Drug Development Stock, Public Company
May 15, 2018 · It is now my pleasure to turn the call over to Onconova's CEO and President, Ramesh Kumar. Dr. Kumar, please proceed. Ramesh Kumar. Thank you, Victor. Good morning and welcome to our...
Nov 13, 2018 · Onconova Therapeutics, Inc. (ONTX) Q3 2018 Results Earnings Conference Call November 13, 2018 9:00 AM ET. Executives. Dr. Ramesh Kumar - Chief Executive Officer Dr. Steven Fruchtman - President
